Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
  • C12M23/00—Constructional details, e.g. recesses, hinges
  • C12M23/02—Form or structure of the vessel
  • C12M23/16—Microfluidic devices; Capillary tubes
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
  • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
  • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
  • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
  • C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
  • C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
  • G01N15/10—Investigating individual particles
  • G01N15/14—Optical investigation techniques, e.g. flow cytometry
  • G01N15/1484—Optical investigation techniques, e.g. flow cytometry microstructural devices
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
  • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
  • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
  • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0809—Geometry, shape and general structure rectangular shaped
  • B01L2300/0829—Multi-well plates; Microtitration plates
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
  • B01L2300/0867—Multiple inlets and one sample wells, e.g. mixing, dilution
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2300/00—Additional constructional details
  • B01L2300/08—Geometry, shape and general structure
  • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
  • B01L2300/0877—Flow chambers
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2400/00—Moving or stopping fluids
  • B01L2400/04—Moving fluids with specific forces or mechanical means
  • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
  • B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2400/00—Moving or stopping fluids
  • B01L2400/04—Moving fluids with specific forces or mechanical means
  • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
  • B01L2400/0457—Moving fluids with specific forces or mechanical means specific forces passive flow or gravitation
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
  • B01L2400/00—Moving or stopping fluids
  • B01L2400/04—Moving fluids with specific forces or mechanical means
  • B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
  • B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
  • G01N15/10—Investigating individual particles
  • G01N2015/1006—Investigating individual particles for cytology
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
  • G01N15/10—Investigating individual particles
  • G01N2015/1027—Determining speed or velocity of a particle

Definitions

• the invention in various embodiments relates to assays, systems, and devices for detecting invasion behavior of cells or related behaviors of other micro-objects using microfluidic systems.
• Particular embodiments involve configurations that can be used with various standard automated handling systems, with active or passive loading and perfusion of medium and to provide high-throughput multi-assay automated systems for analyzing cell invasion, movement, chemotaxis or other properties.
• Microfluidic cell culture is an important technology for applications in drug screening, tissue culturing, toxicity screening, and biologic research and can provide improved biological function, higher- quality cell-based data, reduced reagent consumption, and lower cost.
• High quality molecular and cellular sample preparations are important for various clinical, research, and other applications. In vitro samples that closely represent their in vivo characteristics can potentially benefit a wide range of molecular and cellular applications. Handling, characterization, culturing, and visualization of cells or other biologically or chemically active materials (such as beads coated with various biological molecules) has become increasingly valued in the fields of drug discovery, disease diagnoses and analysis, and a variety of other therapeutic and experimental work.
• One area of interest in cellular assay systems are assays that are able to determine characteristics of cellular migration. Such assays are important in characterization of various types of malignant cells and also in characterization of other cells under various stimulations.
• the present invention involves various components, systems, and methods related to improved microfluidic cell culture devices and systems, in particular systems for the culturing and analysis of invasive or otherwise metastatic or motile cells.
• the invention involves novel microfluidic cell culture devices, systems and methods that have advantages over previously proposed invasion or migration or motility assays using either multi-culture chamber plates or microfluidic structures.
• the invention involves novel structures and methods for integrating multiple microfluidic cell culture and/or cell invasive assay units into various multi cell culture unit systems, such as to a microtiter well plate structure including various standard well plate formats (e.g., a 96-well SBS culture plate, or other plate formats, including plates having 6, 12, 24, 96, 384 or 1536 sample wells, as well as open bottom standard well plates, allowing for attachment to microfluidic structures as described herein.).
• various standard well plate formats e.g., a 96-well SBS culture plate, or other plate formats, including plates having 6, 12, 24, 96, 384 or 1536 sample wells, as well as open bottom standard well plates, allowing for attachment to microfluidic structures as described herein.
• design features include providing an invasion assay device in a convenient format that allows for the elimination of tubing and connectors to the plates themselves, the ability to maintain long-term continuous perfusion cell culture using a passive gravity-driven flow, the ability to perform direct analysis on the outlet wells and/or cellular invasion observation wells or culture wells of the microfluidic plate, the ability to effectively handle gel culture media.
• microfluidic structures and culture units and systems and methods of various configurations as described herein can also be deployed independently of any well-plate, such as in various integrated lab-on-a-chip systems that are not configured to be used in conjunction with well plates or various other microfluidic devices or systems.
• any combination of elements described herein should be understood to include every sub-combination of any subset of those elements and also any sub-combination of any subset of those elements combined with any other element described herein as would be understood to a practitioner of skill in the art.
• the present invention is described in terms of the important independent embodiments of multi-component devices or systems. This should not be taken to limit various novel aspects of the invention, which, using the teachings provided herein, can be applied to a number of other situations.
• the present invention is described in terms of a number of specific example embodiments including specific parameters related to dimensions of structures, pressures or volumes of liquids, temperatures, electrical values, durations of time, and the like. Except where so provided in the attached claims, these parameters are provided as examples and do not limit the invention, which encompasses other devices or systems with different dimensions.
• FIG. 1 is a schematic diagram of an example microfluidic plate design according to specific embodiments, in this example having 24 invasion assay units on a 96 well plate, each unit in this example containing 4 wells: a flow inlet, a cell/gel inlet, an invasion chamber, and a flow outlet.
• (B) is a schematic diagram showing details of one invasion culture unit according to specific embodiments of the invention.
• FIG. 2 are photos illustrating an example single flow unit filled with blue dye with the image taken from top (A) and bottom (B), with the bottom picture taken by flipping the plate in the up-down direction, so that the inlet well is on the left in both pictures.
• FIG. 3A-C are a series of micrographs of regions of the invasion chamber after loading with gel to show invasion assay operation and cellular migration in a gradient according to specific embodiments of the invention.
• FIG.4A-B are micrographs showing cancer cell invasion and cellular migration in a gradient in an assay system and device according to specific embodiments of the invention.
• FIG.5A-B illustrate configuration and operation of an example cell culture chamber design with multiple inlets according to specific embodiments of the invention.
• FIG.6A-C illustrate configuration and operation of an example roughly rectangular cell culture chamber design and gradient chamber design according to specific embodiments of the invention.
• FIG. 7 illustrates a mechanical drawing of an example customized plate frame for microfluidic live cell imaging and illustrating 4 independent units (e.g., rows), a large imaging window for improved optics, air in/out ports (e.g., adjacent to the imaging window), and expanded space between the wells in this example to improve vacuum sealing of the manifold.
• FIG. 8 illustrates a 2 culture unit plate with three flow inlets, an imaging window, a cell inlet, and a flow outlet for each unit according to specific embodiments.
• FIG. 9 illustrates a 16 unit version of a culture unit plate with three flow inlets, an imaging window, a cell inlet, and a flow outlet for each unit according to specific embodiments.
• FIG. 10 illustrates a drawing of an example plate manifold with a gas perfusion line according to specific embodiments of the invention.
• FIG.11A-B are schematics and a photographs illustrating an example of an active control plate according to specific embodiments having four independent culture units, each having 6 flow inlets, a culture chamber and two flow outlets.
• FIG.12A-C is a diagram illustrating a further example culture plate having four independent culture units, each having 6 flow inlets, a culture chamber and two flow outlets that can be used to practice one or more methods described herein according to specific embodiments.
• FIG.13 illustrates one example of cell migration following exposure to a stable gradient according to specific embodiments
• FIG.14 illustrates as an example X/Y cellular migration plots to better illustrate the impact of a gradient on cell movement in a microfluidic cell culture device according to specific embodiments.
• FIG.15 illustrates as an example cell migration as function of distance traveled in a microfluidic cell culture device according to specific embodiments.
• FIG.16 illustrates as an example a plot showing cells exposed to stable gradients in a microfluidic cell culture device move faster than those in stable media environments according to specific embodiments.
• FIG.17 illustrates one example showing that exposure to gradients stimulated active migration of cells towards a high concentration sink according to specific embodiments.
• FIG.18 A-C shows a top view, side view, and plan view of a schematic of an example manifold according to specific embodiments of the invention.
• the eight tubing lines to the right are for compressed air, and each is configured to provide pressure to a column of cell inlet wells in a microfluidic array.
• the left-most line in the figure is for vacuum and connects to an outer vacuum ring around the manifold.
• Each column of wells is generally connected to a single pressure line with wells above imaging regions skipped.
• FIG. 19 illustrates an example system and manifold for operating the microfluidic plates according to specific embodiments of the invention.
• FIG. 20 illustrates a manifold with additional gas line and an objective lens and showing five active wells in a microfluidic plate connected to a culture device according to specific embodiments of the invention.
• FIG. 21 is a block diagram showing a representative example logic device in which various aspects of the present invention may be embodied.
• FIG. 22 (Table 1) illustrates an example of diseases, conditions, or states that can evaluated or for which drugs or other therapies can be tested according to specific embodiments of the present invention.
• a “particle” refers to biological cells, such as mammalian or bacterial cells, viral particles, or liposomal or other particles that may be subject to assay in accordance with the invention. Such particles have minimum dimensions between about 50-100 nm, and may be as large as 20 microns or more. When used to describe a cell assay in accordance with the invention, the terms “particles” and “cells” may be used interchangeably.
• a "microchannel” or “channel” or “flow channel” generally refers to a micron-scale channel used for fluidically connecting various components of systems and devices according to specific embodiments of the invention.
• a microchannel typically has a rectangular, e.g., square, or rounded cross-section, with side and depth dimensions in a preferred embodiment of between 10 and 500 microns, and 10 and 500 microns, respectively. Fluids flowing in the microchannels may exhibit microfluidic behavior.
• the term “microchannel” and “channel” are used interchangeably.
• Flow channel generally denotes channels designed for passage of media, reagents, or other fluids or gels and in some embodiments cells.
• Cell culture channel generally denotes a portion of a cell culture structure that cells are designed to flow through and also remain during cell culture (though the cells may be localized into a particular culture area of the culture channel in some embodiments).
• Air channel generally denotes a roughly micron-scale channel used for allowing gases, such as air, oxygen enriched mixtures, etc., to pass in proximity to flow channels or culture areas.
• Perfusion channel is sometimes used to indicate a flow channel and any perfusion passages or structures that allow media to perfuse to the culture area.
• a 'barrier or “diffusion barrier” or “perfusion barrier” or “mass transfer barrier” refers to a combination of solid structures and passages smaller than the flow channels that generally separate a flow channel from a cell culture area or chamber.
• the passages are generally smaller than the microchannel height and/or width (for example, on the order of 5-50% or on the order of about 10%) and in some embodiments are designed to keep cells, other culture items, and in some embodiments gels, from migrating into the flow channels, while allowing some fluidic flow through diffusion, perfusion, or any combination of mass transfer mechanisms that is generally of a much higher fluidic resistance than the fluid flow in the flow channels.
• the barrier has a passage that is 4 microns high and that otherwise runs most of the length of the microchannel. In other embodiments, a barrier has many passages that are about as high as the microfluidic channel, but about 4 microns wide. A barrier may also allow some migration of cells or cell components through the barrier, or other materials or particles small enough to pass through the passages.
• a "microfluidics device” refers to a device having various station or wells connected by micron- scale microchannels in which fluids will exhibit microfluidic behavior in their flow through the channels.
• a "microwell array” refers to an array of two or more microwells formed on a substrate.
• a “device” is a term widely used in the art and encompasses a broad range of meaning.
• “device” may signify simply a substrate with features such as channels, chambers and ports.
• the “device” may further comprise a substrate enclosing said features, or other layers having microfluidic features that operate in concert or independently.
• the “device” may comprise a fully functional substrate mated with an object that facilitates interaction between the external world and the microfluidic features of the substrate.
• an object may variously be termed a holder, enclosure, housing, or similar term, as discussed below.
• the term “device” refers to any of these embodiments or levels of elaboration that the context may indicate.
• Microfluidic systems provide a powerful tool to conduct biological experiments. Recently, elastomer-based microfluidics has especially gained popularity because of its optical transparency, gas permeability and simple fabrication methods. However, the interface with the end-users requires labor- intensive hole punching through the elastomer, and additional steps of tubing and syringe pump connection.
• the present invention involves integrated microfluidics used for various culture and assay applications.
• the invention further involves methods of manufacture of microfluidics and components and a system for automating cell culture using such plates.
• Advantages of specific embodiments include use of a standard microtiter plate format, tubing free cell culture, and a biomimetic microenvironment for assaying invasion, migration, or chemotaxic cellular behavior.
• a system according to specific embodiments of the invention can be operated using standard techniques and equipment for handling standard microtiter plates, as are well known in the art.
• liquid and/or gel or cell dispensing is achieved with standard pipette mechanics, and cell culture and analysis can be made compatible with existing incubators and plate readers.
• a novel cell loading system uses a pneumatic manifold and pneumatic pressure to place cells in the micro culture area.
• microfluidic cell culture and analysis can be fully automated using other automated equipment that exists for handling standard titer plates.
• the gravity driven flow culture configuration utilizes the medium level difference between the inlet and outlet well as well as engineering the fluidic resistances to achieve the desirable flow rate in nL/min regime.
• This provides the significant advantage of being able to "passively" flow culture medium for long periods of time (e.g., up to 4 days) without the use of bulky external pumps or tubes, which in the case of invasive assays allows for easy set up of the assay and easy reading of invasive assay results at one or more time periods after culture initiation.
• the invention involves a microfluidic system to allow control of the cell culture environment for long-term time -lapse microscopy of adherent and/or invasive or migrating cells.
• the invention provides a multiplexed microfluidic flow chamber allowing for time-lapse microscopy experimentation and examination of cell invasion among other assays.
• the microfluidic chamber uses a perfusion barrier to separate cells from flow channels and an invasion barrier to study the invasive properties of cells between an culture chamber and an invasion chamber.
• Example embodiments are formatted to a standard well plate, allowing liquid and cell/gel samples to be directly pipetted into the appropriate inlet reservoirs using standard equipment.
• a custom pneumatic flow controller can be used to load the cells into the culture regions as well as to switch between different exposure solutions.
• a digital software interface can be used to allow a user to program specific inputs (pulses, ramps, etc.) over time to expose the cells to complex functions during time -lapse imaging.
• Dynamic responses in living cells are the foundation for phenomena such as biological signal processing, gene expression regulation, differentiation, and cell division.
• the invention involves a system capable of controlling the cellular micro-environment in a multiplexed format compatible with current cell culture methods.
• Cell response can be quantified using high magnification fluorescence microscopy to derive kinetic information with sub-cellular resolution. This capability has broad applications in cellular systems biology where dynamic single cell response experiments are not currently practical. While some invasion assay embodiments according to specific embodiments can use mostly or fully passive systems with exposure to just one medium/reagent mixture other invasion assays according to specific embodiments can be performed using complex reagent scheduling using a manifold as described herein.
• one or more micro culture areas are connected to a medium or reagent channel via a grid of fluidic passages (or diffusion inlets or conduits), wherein the grid comprises a plurality of intersecting high fluidic resistance perfusion passages.
• passages in the grid are about 1 to 4 ⁇ in height, 25 to 50 ⁇ in length and 5 to 10 ⁇ in width, the grid allowing for more even diffusion between medium or reagent channels and the culture area and allowing for easier manufacturing and more even diffusion.
• the high fluidic resistance ratio between the microchamber and the perfusion/diffusion passages or grid offers many advantages for cell culture such as: (1) size exclusion of cells; (2) localization of cells inside a microchamber; (3) promoting a uniform fluidic environment for cell growth; (4) ability to configure arrays of microchambers or culture areas; (4) ease of fabrication, and (5) manipulation of reagents without an extensive valve network. Examples were illustrated wherein a grid-like perfusion barrier can be much shorter than the culture area or can be near to or at the same height, according to specific embodiments of the invention and further wherein various configurations for culture devices were illustrated.
• the invention further comprises a microfluidic plate for 3D cancer cell invasion assays.
• the plate uses the standard 96 well plate format with 4 wells connected by microfluidic channels to create each individual flow and invasion assay unit (with, e.g., 24 units per plate in specific embodiments).
• flows are driven by capillary force and gravity as discussed elsewhere herein, allowing the plates to be operated in a standard incubator with no external connections after initial introduction of cells and culture media.
• a device of the invention receives cells in a 3D gel into a culture chamber.
• the culture chamber is separated by an invasion barrier from an invasion chamber and both are separated from the flow channel by a set of, for example, 8x8 micron cross section microfluidic pores or passages (at times herein referred to as the invasion barrier) thus modeling the in vivo environment for tumor invasion.
• FIG. 1 (A) is a schematic diagram of an example microfluidic plate design according to specific embodiments, in this example having 24 invasion assay units on a 96 well plate, each unit in this example containing 4 wells: a flow inlet, a cell/gel inlet, an invasion chamber, and a flow outlet.
• liquid in the flow inlet, cell/gel inlet, and flow outlet are in contact with the microchannels.
• the well above the invasion chamber is left empty for better imaging quality.
• the bottom surface of the plate is a glass slide.
• There are 24 flow units per plate (each unit is 1 well by 4 wells, forming an 8x3 array on the 8x12 well plate).
• FIG. 1A-B the figure provides three levels of magnification.
• This invasion assay/culture area can be understood as comprising 5 primary regions.
• a cell/gel loading channel is shown at the bottom of the figure.
• cells mixed in a gel e.g. Matrigel, collagen, fibrin, etc.
• the channel is designed so that the gel fills the loading channel and also fills the invasion barrier and part or all of the invasion chamber, but not past the perfusion barrier.
• the loading channel is 550 ⁇ in width and 50 ⁇ in height.
• the loading channel is separated from an invasion chamber by an invasion barrier.
• the invasion barrier consists of a network of channels of approximately 50 ⁇ 8 ⁇ 8 ⁇ (LxWxH) dimensions. These are or become filled with gel or liquid in some embodiments and mimic the endothelial barrier in tissue. Invasive cancer cells are able to move through the narrow channels of the invasion barrier into the invasion chamber.
• the invasion chamber in this example about 4.8 x 0.5 x .05 mm in dimension (LxWxH) and is used to count the number of cells that invade or migrate from the loading channel past the invasion barrier. During assay operation, cells in this chamber can be counted by manual or automated microscope or other means and quantified to determine an invasion index for the well.
• the perfusion barrier is a network of channels of, in specific embodiments, dimensions of 100x4x2 ⁇ (LxWxH), that separates the invasion chamber from the flow channel.
• the narrow cross section prevents cells and gels from passing through the infusion barrier.
• Medium and drugs carried in the medium, including chemoattractants, dyes, or other materials used in an invasion assay or in cell culture) diffuse across the perfusion barrier and form a gradient to the invading cells, modeling the tumor environment in the vasculature.
• An 100x50 ⁇ (WxH) flow channel carries fluid from the flow inlet well past the invasion chamber and empties to the flow outlet well. Diffusion of nutrients from the flow through the perfusion barrier feeds the cells. This channel simulates the blood flow in the body.
• the gravity driven flow rate is set to -20 ⁇ /day, allowing for >3 day continuous flow experiments without refilling the wells.
• dimensions provided herein are for an example culture unit. According to various specific embodiments, any dimensions suitable for a particular media or culture item can be used in accordance with other teachings provided herein.
• the invasion assay unit as described above is configured into a standard culture well plate to allow for simultaneous running of multiple invasion assay experiments. These experiments can include multiple assays for a single subject, either of the same or different tissue samples, multiple assays from different subjects, and can include assays that expose cells to different media, hormonal or other stimuli, drugs, chemoattractants, etc.
• FIG. 2 are photos illustrating an example single flow unit filled with blue dye with the image taken from top (A) and bottom (B), with the bottom picture taken by flipping the plate in the up-down direction, so that the inlet well is on the left in both pictures.
• FIG. 3A-C are a series of micrographs of regions of the invasion chamber after loading with gel to show invasion assay operation and cellular migration in a gradient according to specific embodiments of the invention.
• Matrigel mixed with fluorescent dye (red) was loaded by capillary flow into the loading channel and polymerized at 37C for 15 minutes.
• FIG. 3 A illustrates 40X magnification of the invasion chamber showing the gel fills the loading channel, invasion barriers, and part of the invasion chamber.
• FIG. 3B shows 200X magnification of the invasion barriers. The polymerized gel can be seen inside the invasion barriers, as well as in the invasion chamber.
• FIG. 3C shows 200X magnification of the perfusion barrier, showing the gel is unable to cross the narrow channel network.
• the "gel” can have various viscosities down to a fluid viscosity in specific embodiments and specific tests.
• the perfusion barrier allows for use of a wider range of gel viscosities according to the invention.
• FIG.4A-B are micrographs showing cancer cell invasion and cellular migration in a gradient in an assay system and device according to specific embodiments of the invention.
• HT-1080 invasive human breast cancer cells were loaded in 3D Matrigel and perfused with medium containing 10% serum.
• FIG.4A shows cells immediately after loading and polymerization of the gel are located on the bottom side of the invasion barrier.
• FIG.4B shows cells after 24 hours of perfusion culture with serum containing medium (known signal for HT-1080 invasion), some of the cells have migrated through the Matrigel and invasion barriers to occupy the invasion chamber. Images taken with phase contrast at 40X magnification.
• various strategies can be used to remove some of all of the cells in the invasion chamber for further analysis.
• the invention further facilitates this by providing a culture environment in the invasion chamber that sustains the cells until they are removed.
• air diffusion through the material that defines the microfluidic channels can be facilitated by air passages and air holes as described elsewhere herein.
• PDMS silicone elastomer polydime-thylsiloxane
• the structures disclosed above can also be adapted to systems using more or fewer wells on a standard microtiter well plate or a fully customized or partially customized plate, such as those described in referenced documents and in other examples herein.
• Plates and systems as described herein can be used with other configurations of cell culture areas and invasion chambers and micro-fluidic flow structures as described in above referenced patent applications.
• the cell culture area provided is an essentially rectangular cell culture chamber.
• the cell culture chamber has cell inlet and outlet passages at the right, and flow outlets also at the right.
• the cell passages are paired, with the center pair used for cell flow loading and the pairs on either side used as a cell flow outlet.
• the invasion assay proceeds as outlined above, after any invasive cells have had sufficient time to move through the invasion barrier.
• FIG.5A-B illustrate configuration and operation of an example cell culture chamber design with multiple inlets according to specific embodiments of the invention.
• This example includes a cell/gel perfusion barrier with a cross-hatch perfusion passage design and an invasion barrier as discussed above.
• the cross hatch design allows cells in a gel matrix to be flowed into the chamber and allows for perfusion of media. While the cross-hatch perfusion barrier is presently preferred in some designs, culture chambers with different perfusion barriers or no perfusion barriers are also implemented according to specific embodiments.
• a flow around channel for media includes an outlet and inlet both on the same side of the barrier.
• FIG.5 A illustrates a general embodiment where the outlet and inlet openings are shown to the right.
• FIG.5B illustrates an inlet channel to the left and outlet channel to the right, which configuration is better suited in some example systems using a well plate as described herein.
• This figure also provides detailed example dimensions of a sample design according to specific embodiments of the invention.
• a cell culture chamber is modified to allow easier culture of cells in 3D gel matrix.
• a perfusion barrier separates the cell culture area and the flow channel as illustrated.
• the barrier is designed to retain a 3D gel in the culture chamber. Coupling the barrier with the 3-channel cell/gel inlet design described above is an important feature that provides improved performance. By having separate flow inlets/outlets on each side of the barrier, it is possible to localize a fluid gel in the culture chamber, and not have it obstruct the flow channel.
• An invasion barrier as described above is placed in the region indicated by the dashed line in the figure and is used to separate the cell entry and culture chamber from the invasion chamber, as will be understood from the teachings herein.
• perfusion channels may be provided so that they are only adjacent to the invasion chamber.
• the invention provides a 3D gel environment for biologic cell culture and invasion assays, for example using a temperature sensitive gel culture matrix, such as MatrigelTM, GeltrexTM, collagen, etc.
• a temperature sensitive gel culture matrix such as MatrigelTM, GeltrexTM, collagen, etc.
• An example gel is liquid at 4C, which, for example polymerizes at room temperature or 37 C.
• cells are initially mixed with a cell suspension on ice.
• the solution is then pipetted into the cell inlet well, and carried into the microfluidic chambers and the culture and invasion chambers via capillary flow.
• the plate is kept at room temperature.
• the flow rate allows sufficient cell/gel solution to fully fill the culture chamber prior to polymerization while the cells do not enter the invasion chamber during fluid flow because of the size of the invasion passages.
• the perfusion barrier prevents any of the gel solution from leaking into the flow channel. As the gel warms up, it polymerizes into a semi-solid mass, with cells embedded in the culture region. Flow of media in the flow channel diffuses into the cell culture chamber through the invasion chamber and through the gel and nourishes the cells for culture while providing an attractant for invasive cells to move through the invasion barrier to the invasion chamber.
• This novel design allows the invention to provide a 3D gel culture system in a microfluidic device while avoiding the problem of having gel block the flow channels.
• the blue areas indicate air flow, and are optional and not present in all embodiments.
• the gray areas indicate a fluid channel, with an example height of around 40 ⁇
• the red area indicates cell culture and invasion areas, with an example height of around 200 ⁇
• the green area indicates a perfusion barrier with an example height of around 2 ⁇ .
• the yellow invasion barrier will generally have the same height or similar height as the culture areas (e.g., 200 ⁇ ), but will have invasion barrier structures as described above.
• the invasion assay proceeds as outlined above, after any invasive cells have had sufficient time to move through the invasion barrier.
• multiplexed perfusion imaging of cells can be performed in a 3D gel matrix.
• An example plate contains 24 independent culture units that can be loaded with cells/gel as a user chooses.
• each row of the plate contains 3 fully independent flow units (4 wells each), consisting of a medium inlet (e.g., cols. 1, 5 , 9), a cell culture/invasion/imaging well (e.g., cols. 2, 6, 10), cell/gel inlet (cols. 3, 7, 10), and an outlet (cols 4, 8, 12).
• Air diffusion channels blue provide gas transfer to the cells.
• the inlets are designed to allow continuous flow of culture media to the cells at 40 ⁇ /day via a gravity driven process.
• each chamber is 1.5 x 0.5 mm in size, with a height of 200 ⁇ .
• the perfusion barrier ensures uniform nutrient transfer through the gel matrix and a thin cover glass bottom (170 ⁇ ) allows for optimum image quality.
• An invasion barrier provides separation between a culture region and an invasion region. 3D gel loading in such a system can be performed as described above and in incorporated references.
• any of the various novel microfluidic cell culture chambers and associated microfluidic structures can, according to specific embodiments of the invention, be integrated with a well titer plate device as is commonly used in macro cell culturing assays.
• a well titer plate device as is commonly used in macro cell culturing assays.
• a number of specific examples are provided below, though the invention encompasses other systems for integrating with the microfluidic devices.
• each culture unit consists of 4 well positions. The first well is for perfusion medium, the second well is for cell inlet, the third well is for imaging the microfluidic chamber, and the fourth well is the outlet.
• a cell barrier/perfusion channel localizes cells to the cell area and improves nutrient transport during continuous perfusion culture.
• the low fluidic resistance of the cell inlet to outlet path enables cells to be rapidly loaded via gravity or surface tension methods without an external cell loading mechanism.
• the high fluidic resistance of the perfusion inlet flow channels allows long term continuous perfusion of medium via gravity flow without any external pump mechanism.
• An invasion barrier operates to separated cultured cells from an invasion region for invasion assays.
• the cell chamber is designed to mimic the interstitial tissue environment, with cells embedded or overlayed in physiologic extracellular matrix (ECM), and fed via diffusion from a continuously perfused capillary channel.
• ECM extracellular matrix
• the cell microenvironment enables long term growth in, e.g., a 200 micron thick gel layer. Oxygenation channels maintain adequate gas transport, and the glass coverslide bottom allows high quality cell imaging.
• the standard layout allows the advanced microfluidic units to be operated just like a typical 96-well plate.
• the gravity driven perfusion design eliminates the need for pump or tubing connections, as described above.
• an expected number of cells per unit is about 500 cells.
• An example perfusion rate is 40 ul/day for a single unit.
• the cell chamber volume is 150 nL, and the chamber dimensions are 1.5x0.5x0.2 mm.
• the gas diffusion membrane is 50 um silicone with a bottom surface #1.5 thickness coverglass.
• An open top microfluidic cell culture chamber for continuous perfusion can also be modified with a second barrier separating an invasion region from a culture region.
• FIG.6A-C illustrate configuration and operation of an example roughly rectangular cell culture chamber design and gradient chamber design according to specific embodiments of the invention.
• the cell culture area provided is an essentially rectangular cell culture chamber.
• the cell culture chamber as illustrated in FIG.6 A and FIG.6B has cell inlet and outlet passages E2 shown at the right, and flow outlets El also shown at the right.
• the cell passages are paired, with the center pair used for cell flow loading and the pairs on either side used as a cell flow outlet.
• Multiple separate flow inlets are shown on the left, labeled Al, A2, B l, B2, CI, C2 and in this example design the flow inlets have a grid pattern to prevent blockage by cells.
• Air diffusion channels are shown surrounding the chamber.
• Outlet El provides an outlet for fluid flow that is partially isolated from the culture chamber.
• FIG.6B illustrates cell loading in a culture unit as shown in FIG.6A.
• Cells are loaded via a low resistance fluidic path (with higher resistance in the flow paths).
• the cells are prevented from blocking the flow paths by the resistance ratio (the cells preferentially flow to the cell outlet instead of the flow channels).
• the channels in this particular embodiment are arranged such that the cell in and cell out channels are on the right side of the chamber. This results in the unique feature where flow of cells goes into the chamber, makes a 180 degree turn, and flows out, as illustrated by the sharply curved streamlines shown in FIG.6B from the Cell In to Cell Out passages.).
• cells are loaded (via capillary force) from the center right channel(s) and out from the top and bottom right channels.
• a very small amount of flow is directed towards the side outlet channels (the longer less curved streamlines shown in FIG.6B exiting at the left edge of the chamber).
• the side flow is not important for cell loading, but serves to help distribute cells more evenly in the chamber. Because of the low velocity of the flow, the cells naturally settle onto the chamber floor without needing any physical barrier.
• the cell outlet paths help make the loading symmetric, as well as to increase the number of cells loaded into the chamber.
• This loading mechanism can be used to load cells, particles, beads, gels, gels with cells, etc.
• FIG.6C shows use of a design such as in FIG.6A-B to establish a stable gradient in a cell .cell culture chamber design according to specific embodiments of the invention.
• the example design in FIG.6C differs only slightly from that of FIG.6A-B and operation modes described for one of these two designs herein apply to the other.
• the cell passages are unpaired. Three unpaired flow inlets are shown on the left and these also have a grid pattern to prevent blockage by cells. Air diffusion channels generally are placed near the chamber, though not shown in this figure.
• FIG.6C further illustrates creating a gradient in the culture chamber by flowing 2 (or more) solutions at once according to specific embodiments of the invention in the microfluidic device as described above.
• FIG. 7 illustrates a mechanical drawing of an example customized plate frame for microfluidic live cell imaging and illustrating 4 independent units (e.g., rows), a large imaging window for improved optics, air in/out ports (e.g., adjacent to the imaging window), and expanded space between the wells in this example to improve vacuum sealing of the manifold.
• FIG. 8 illustrates a 2 culture unit plate with three flow inlets, an imaging window, a cell inlet, and a flow outlet for each unit according to specific embodiments.
• FIG. 9 illustrates a 16 unit version of a culture unit plate with three flow inlets, an imaging window, a cell inlet, and a flow outlet for each unit according to specific embodiments.
• FIG. 10 illustrates a drawing of an example plate manifold with a gas perfusion line according to specific embodiments of the invention.
• FIG.11A-B are schematics and a photographs illustrating an example of an active control plate according to specific embodiments having four independent culture units, each having 6 flow inlets, a culture chamber and two flow outlets.
• FIG.11A shows a plate design with 4 independent flow units (rows of the plate) with 6 inlet solutions, an open chamber or other culture chamber, an outlet, and a gravity flow channel.
• FIG.11B shows the four open chambers (green circles), with inlet streams above and outlet streams below the open chamber. The design allows flows to pass from the inlet to outlet channels without overflowing the open chamber.
• the availability of multiple liquid or reagent inlets provides systems that are particularly good for live cell imaging and other experiments and assays in cell biology.
• a research can study cultures of pancreatic or other organ cells, or cancer cells, to determine how they respond to different drugs or other stimulus introduced via the inlets.
• a gravity well is also provides to facilitate maintaining (e.g., feeding) the cells before experiments are performed.
• the plate can be sealed to a pneumatic manifold, allowing pressure driven control of the 6 inlet solutions. This allows experiments where solutions are quickly changed over the cells. Pressure driven flow of up to 10 PSI is possible due to the large resistance region between the inlet and culture chamber, leading to a pressure near the chamber less than l/lOOO ⁇ the input pressure.
• FIG. 1 The figures illustrate the layout of the active control plate with 4 independent units (rows), 6 upstream inlets (A1-A6, B 1-B6, C1-C6, D1-D6), a central imaging window with four culture chambers, a large outlet well (oval, A7, B7, C7, D7), and gravity perfusion well (last column, A8, B8, C8, D8).
• FIG.12A-C is a diagram illustrating a further example culture plate having four independent culture units, each having 6 flow inlets, a culture chamber and two flow outlets that can be used to practice one or more methods described herein according to specific embodiments.
• This plate first marketed in June 2010, has 4 independent culture chambers (for example, A-D), each with a gravity flow inlet (1), four solution inlets (2-5), a cell inlet (6), and two shared outlet wells (7 and 8).
• A-D independent culture chambers
• All four culture chambers are located under a single imaging window to minimize travel distance for high magnification phase objectives
• the chamber is bound by perfusion barriers on the top and bottom edges to separate the chamber from flow channels.
• Inlet wells 2 and 3 flow media into the upper channel, while 4 and 5 flow media through the lower channel. Gradients are established by simultaneously flowing media of different compositions through the upper and lower channels. Due to continuous perfusion, a stable gradient can be maintained for extended periods (> 2 days).
• the most widely accepted cell migration assay is the Boyden chamber assay, using a two- chamber multi-well plate in which a membrane in each well provides a porous interface between two chambers. Chemoattractant is placed in the lower chamber, and the system is allowed to equilibrate, with the expectation that a gradient would form between the upper and lower wells. However, in reality, very steep gradients can form along a single axis perpendicular to the surface of the membrane, resulting in a lower- than-expected difference in chemoattractant concentration between upper and lower wells.
• this method is unsuitable for correlating specific cell responses with particular gradient characteristics (i.e., slope, concentration, temporal evolution, etc) and for studying multi-gradient signal integration.
• gradients are not very stable under "static" cell culture conditions, precluding live cell imaging.
• a cell culture chamber or system such as shown in the above figures, can further be used to create a quantitatively defined diffusion gradient that is stable enough for long- term, live cell imaging over the course of days.
• a microfiuidic gradient culture chamber of plate according to specific embodiments and methods described herein, enables precision-controlled chemoattractant diffusion across perfusion barriers to create a spatial gradient in the culture area
• the flow inlets and outlets of culture chambers form a continuous-flow "infinite source/sink" that maintains a stable concentration gradient profile for days.
• changes in gradient directionality, turning gradients on and off, and toggling between gradient and single solution exposure are possible.
• long-term, live imaging of cells on a stable chemoattractant gradient can be used to study malignant cells or other cells capable of motility or migration.
• a serum gradient according to specific embodiments on metastatic breast cancer cell migration distance, velocity, and degree of chemotaxis are characterized in detail.
• MDA-MB-231 (HTB-26TM, ATCC®), a human breast cancer line derived from a metastatic pleural effusion site, was maintained in complete medium (Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10°/ov/v fetal bovine serum (FBS), 1 % nonessential amino acids, 2 mM L-glutamine and antibiotics (all EMD Millipore)) and passaged routinely by trypsinization (TrypLETMSelect, GIBCO) to ensure log phase growth.
• DMEM Dulbecco's Modified Eagle Medium
• FBS fetal bovine serum
• TrypLETMSelect GIBCO
• FIG.13 illustrates one example of cell migration following exposure to a stable gradient according to specific embodiments
• MDA-MB-231 cell migration is shown following exposure to a stable FBS gradient using one of more of the gradient culture chambers described above.
• This example shows representative images (10X magnification) from cell chambers where cells were incubated in complete medium or exposed to a 0-10% FBS gradient established along the Y-axis (vertical plane).
• the top panel contains images captured 24 hours after cell loading.
• the middle panel shows cells 96 hours post-loading; the culture time is broken down into three days in complete medium followed by 24 hours of serum starvation (no FBS). It is apparent from the images that both cell expansion and movement occurred during the three-day interval. Images in the bottom panel were taken 12 hours after gradient induction.
• FIG.13 shows the migration of single MDA-MB-231 cells in response to FBS gradients over the course of three days. Both cell expansion and movement occurred during the three-day interval between the top and middle rows. Images in the bottom panel were taken 12 hours post gradient induction. In general, for those cultures exposed to a FBS gradient, there is an obvious movement of cells along the Y-axis toward the upper barrier of the cell chamber. By contrast, control cells cultured in the absence of a spatial serum gradient demonstrated less movement with far more random directional properties. The boxes (numbered 1-8) in the middle and bottom panels were used to identify particular cells and demonstrate their overall movement within the 12-hour time frame. Overall, cells exposed to FBS gradients tended to move preferentially toward the source of higher FBS concentration.
• FIG.14 illustrates as an example X/Y cellular migration plots to better illustrate the impact of a gradient on cell movement in a microfluidic cell culture device according to specific embodiments.
• the plot is an X/Y migration plots to illustrate the impact of a stable gradient in a microfluidic culture unit (e.g., an FBS gradient on MDA-MB-231) cell movement. Shown in this specific example are four plots: (a) 0/0 FBS (no gradient), (b) 10/10 FBS (no gradient), (c) 10/0 FBS (bottom to top gradient), and (d) 0/10 FBS (top to bottom gradient).
• each data set was derived from 50 representative cells from a single cell culture chamber that were tracked for the initial 36 image frames of the time-lapse video (12 hours).
• Black and Red lines specify cells that possessed a net "upward” or “downward” movement relative to the Y-axis, respectively.
• Image J software was used to track the migratory properties of individual cells under various culture conditions. In some of these examples, 50 cells were monitored for a total of 12 hours; the results are presented in the X/Y-plots of FIG.14. The analysis shows that (1) cells tended to move to a far lesser degree in stable medium than when exposed to a nutrient gradient, and (2) cell migration was significantly more directed when a gradient was established within the culture chamber. [0085] To distinguish chemotaxis toward the FBS from nondirectional migration, we analyzed movement in the x direction (perpendicular to gradient) separately from y-axis (parallel to gradient) movement (Figure 6). Significant chemotaxis was only exhibited by cells exposed to an FBS gradient (10/0 FBS A-C and 0/10 FBS). Cells in a spatially-constant FBS culture demonstrated very little overall movement.
• FIG.15 illustrates as an example cell migration as function of distance traveled in a microfluidic cell culture device according to specific embodiments.
• MDA-MB-231 cell migration as function of distance traveled is shown.
• n 50 representative cells for each
• the mean distance migrated (in ⁇ ) was measured as a function of total (a) and Euclidean distance (b), where the latter represents a straight line from starting to end position.
• FIG.16 illustrates as an example a plot showing cells exposed to stable gradients in a microfluidic cell culture device move faster than those in stable media environments according to specific embodiments.
• This example shows that in some cases, cells exposed to gradients (e.g., FBS) move faster than those in stable media environments.
• This graph demonstrates the difference in migration velocity ( ⁇ / ⁇ ) among the four culture conditions in this example. Velocities were calculated based on mean total distance migrated.
• FIG.17 illustrates one example showing that exposure to gradients stimulated active migration of cells towards a high concentration sink according to specific embodiments.
• exposure to FBS gradients stimulated active migration of MDAMB-231 cells towards the high concentration sink.
• the migration index provides a measurement of the movement of cells (relative to their position of origin) in both the X (perpendicular to the gradient) and Y (parallel with the gradient) directions.
• both values for both planar movements are displayed (each bar represents the mean of 50 individually-tracked cells within a single cell chamber).
• ambient temperature within the cell culture chamber was calibrated to 37 °C using the CellASICTM ONIX Microincubator Controller, Temperature Calibration Plate and DirecTempTM temperature monitoring software (EMD Millipore).
• Cell chambers were primed using phosphate -buffered saline (PBS) solution that was aspirated from wells 1, 6, 7 and 8 of the CellASICTM plate and 10 uL culture media was pipetted into well 6. The procedure was repeated for all chamber units on the microplate. The plate was vacuum-sealed to the F84 Manifold. Using the CellASICTM ONIX FG software, medium was set to perfuse from well 6 at 0.25 psi for 2 minutes.
• PBS phosphate -buffered saline
• 300 uL complete medium and complete medium minus FBS were loaded into inlet wells 2 and 4, respectively, and flowed simultaneously at 1 psi.
• the gradient's orientation was reversed by switching the source wells for perfusion.
• complete medium minus FBS and complete medium were loaded into wells 3 and 5, respectively, and flowed simultaneously at 1 psi.
• a proprietary pneumatic manifold as described herein and in the above referenced applications may be mated to the plate and pneumatic pressure is applied to the cell inlet area for cell loading and for culturing during invasion assays.
• a novel cell loading system uses a pneumatic manifold and pneumatic pressure to place cells in the micro culture area.
• microfluidic cell culture and analysis can be fully automated using other automated equipment that exists for handling standard titer plates.
• the invention involves a microfluidic system to allow control of the cell culture environment for long-term time -lapse microscopy of adherent cells.
• the invention provides a multiplexed microfluidic flow chamber allowing for time -lapse microscopy experimentation among other assays.
• the microfluidic chamber uses an artificial endothelial barrier to separate cells from flow channels.
• the device is formatted to a standard well plate, allowing liquid and cell samples to be directly pipetted into the appropriate inlet reservoirs using standard equipment.
• a custom pneumatic flow controller is then used to load the cells into the culture regions as well as to switch between different exposure solutions.
• a digital software interface can be used to allow a user to program specific inputs (pulses, ramps, etc.) over time to expose the cells to complex functions during time -lapse imaging.
• Dynamic responses in living cells are the foundation for phenomena such as biological signal processing, gene expression regulation, differentiation, and cell division.
• the invention involves a system capable of controlling the cellular micro-environment in a multiplexed format compatible with current cell culture methods.
• Cell response can be quantified using high magnification fluorescence microscopy to derive kinetic information with sub-cellular resolution. This capability has broad applications in cellular systems.
• FIG.18 A-C shows a top view, side view, and plan view of a schematic of an example manifold according to specific embodiments of the invention.
• the eight tubing lines to the right are for compressed air, and each is configured to provide pressure to a column of cell inlet wells in a microfluidic array.
• the left-most line in the figure is for vacuum and connects to an outer vacuum ring around the manifold.
• Each column of wells is generally connected to a single pressure line with wells above imaging regions skipped.
• the manifold is placed on top of a standard well plate or other configuration of plate.
• a rubber gasket lies between the plate and manifold, with holes matching the manifold (not shown).
• the vacuum line creates a vacuum in the cavities between the wells, holding the plate and manifold together. Pressure is applied to the wells to drive liquid into the microfluidic channels (not shown). A typical pressure of 1 psi is used, therefore the vacuum strength is sufficient to maintain an air-tight seal.
• each column is connected to a single pressure line. Columns above the cell imaging regions are skipped.
• Pressurized cell loading in a system according to specific embodiments of the invention has been found to be particularly effective in preparing cultures of aggregating cells (e.g., solid tumor, liver, muscle, etc.). Pressurized cell loading also allows structures with elongated culture regions to be effectively loaded. Use of a pressurized manifold for cell loading and passive flow for perfusion operations and invasion assay allows the invention to utilize a fairly simple two inlet design, without the need for additional inlet wells and/or valves as used in other designs.
• a plate manifold includes an additional "gas line" that is used to bathe the cells in the microfluidic device with a specified gas environment (for example, 5% C0 2 ).
• a specified gas environment for example, 5% C0 2
• Other examples include oxygen and nitrogen control, but any gaseous mixture can be sent to the cells.
• the gas flows through the manifold into the sealed wells above the cell culture area and holes in the microfluidic device enable the gas to flow into specified microfluidic air channels, as described above.
• the gas permeable device layer allows the gas to diffuse into the culture medium prior to exposing the cells. By continuously flowing the gas through the microfluidic plate, a stable gas environment is maintained.
• This provides an optional means for controlling the gas environment to placing the microfluidic plate into an incubator.
• the manifold can be used to create a "micro-incubator" independent of the ambient air.
• FIG. 19 illustrates an example system and manifold for operating the microfluidic plates according to specific embodiments of the invention.
• a robotic arm moves the microfluidic plates from station to station.
• An automated incubator stores the plates at the proper temperature and gas environment for long term perfusion via gravity flow.
• the pipettor dispenses liquids (media, drugs, assay reagents, etc.) to the inlet wells and removes liquid from the outlet wells.
• a plate reader is used for assay.
• the cell loader is optionally used to introduce the cells to the microfluidic arrays at the beginning of the experiment.
• the cell loader in particular is generally not "off-the-shelf and operates by applying pneumatic pressure to specified wells of the array plate to induce flow. Standard or custom computer software is available to integrate operations.
• the basic process includes: 1) removing the plate from the incubator, 2) removing liquid from the outlet wells via the pipettor, 3) moving a media/drug storage plate from the "plate stacks," 4) transferring liquid from the media/drug plate to the microfluidic plate via the pipettor, 5) placing the microfluidic plate into the incubator, 6) repeat for each plate, 7) repeat after specified time interval (e.g. 24 hours).
• the 96-well plate standard allows the microfluidic system to be operated using standard techniques and equipment. For example, liquid dispensing is achieved with standard pipette mechanics, and cell culture and analysis is compatible with existing incubators and plate readers. A custom built cell loading system can be used to load the cells using air pressure as described above.
• the gravity driven flow culture configuration utilizes the medium level difference between the inlet and outlet well as well as engineering the fluidic resistances to achieve the desirable flow rate in nL/min regime. This provides the significant advantage of being able to "passively" flow culture medium for long periods of time (for example, up to 4 days) without the use of bulky external pumps.
• Integrated systems for the collection and analysis of cellular and other data as well as for the compilation, storage and access of the databases of the invention typically include a digital computer with software including an instruction set for sequence searching and/or analysis, and, optionally, one or more of high-throughput sample control software, image analysis software, collected data interpretation software, a robotic control armature for transferring solutions from a source to a destination (such as a detection device) operably linked to the digital computer, an input device (e.g., a computer keyboard) for entering subject data to the digital computer, or to control analysis operations or high throughput sample transfer by the robotic control armature.
• the integrated system further comprises valves, concentration gradients, fluidic multiplexors and/or other microfluidic structures for interfacing to a microchamber as described.
• software for providing the data and/or statistical analysis can be constructed by one of skill using a standard programming language such as Visual Basic, Fortran, Basic, Java, or the like.
• a standard programming language such as Visual Basic, Fortran, Basic, Java, or the like.
• Such software can also be constructed utilizing a variety of statistical programming languages, toolkits, or libraries.
• FIG. 21 shows an information appliance (or digital device) 700 that may be understood as a logical apparatus that can read instructions from media 717 and/or network port 719, which can optionally be connected to server 720 having fixed media 722. Apparatus 700 can thereafter use those instructions to direct server or client logic, as understood in the art, to embody aspects of the invention.
• One type of logical apparatus that may embody the invention is a computer system as illustrated in 700, containing CPU 707, optional input devices 709 and 711, disk drives 715 and optional monitor 705.
• Fixed media 717, or fixed media 722 over port 719 may be used to program such a system and may represent a disk- type optical or magnetic media, magnetic tape, solid state dynamic or static memory, etc.
• the invention may be embodied in whole or in part as software recorded on this fixed media.
• Communication port 719 may also be used to initially receive instructions that are used to program such a system and may represent any type of communication connection.

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• General Health & Medical Sciences (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Wood Science & Technology (AREA)
• Biochemistry (AREA)
• Immunology (AREA)
• Analytical Chemistry (AREA)
• Organic Chemistry (AREA)
• Zoology (AREA)
• Cell Biology (AREA)
• Hematology (AREA)
• Biotechnology (AREA)
• Microbiology (AREA)
• Dispersion Chemistry (AREA)
• Genetics & Genomics (AREA)
• Pathology (AREA)
• Urology & Nephrology (AREA)
• Sustainable Development (AREA)
• Physics & Mathematics (AREA)
• General Physics & Mathematics (AREA)
• Clinical Laboratory Science (AREA)
• General Engineering & Computer Science (AREA)
• Molecular Biology (AREA)
• Tropical Medicine & Parasitology (AREA)
• Toxicology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Food Science & Technology (AREA)
• Medicinal Chemistry (AREA)
• Apparatus Associated With Microorganisms And Enzymes (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)

Priority Applications (4)

Applications Claiming Priority (4)

Publications (1)

Family

ID=49300898

Family Applications (1)

Country Status (5)

Cited By (12)

Families Citing this family (10)

Citations (3)

Family Cites Families (3)

• 2013
  • 2013-02-06 EP EP13772405.0A patent/EP2834649A4/en not_active Withdrawn
  • 2013-02-06 WO PCT/US2013/024999 patent/WO2013151616A1/en active Application Filing
  • 2013-02-06 CN CN201380018324.1A patent/CN104412109A/zh active Pending
  • 2013-02-06 CN CN201610259619.3A patent/CN106399094A/zh active Pending
  • 2013-02-06 JP JP2015503203A patent/JP2015517804A/ja active Pending
  • 2013-02-06 SG SG11201405210QA patent/SG11201405210QA/en unknown
  • 2013-02-06 SG SG10201803961VA patent/SG10201803961VA/en unknown
  • 2013-02-06 SG SG10201607963SA patent/SG10201607963SA/en unknown
• 2017
  • 2017-02-06 JP JP2017019804A patent/JP2017093467A/ja active Pending

Patent Citations (3)

Non-Patent Citations (3)

Also Published As

Similar Documents

Legal Events